News

The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of ...
AnaptysBio offers significant upside, with fair value estimates nearly double its current market cap if RA approval is ...
A precision oncology Pfizer drug now has clinical data showing it helped patients with colorectal cancer live longer, results that study investigators say could change the way physicians treat ...
This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...
The FDA will stop annual COVID vaccines for many people under age 65 this fall. Eligibility will be tied to specific medical conditions like asthma, HIV and pregnancy. Vaccines remain free for ...
Pharmacokinetics: The pharmacokinetic profile of DF-003 was largely dose proportional and the data support additional clinical trials as a once-daily, orally administered drug. “We are happy to share ...
The Food and Drug Authority (FDA) has called on industry players to ensure that product advertisements strictly adhere to the guidelines established by the Authority. According to the Authority, a lot ...
SAN DIEGO (FOX 5/KUSI) — The U.S. Food and Drug Administration is implementing ... them at a high-risk for severe illness. These new guidelines were published Tuesday in the New England Journal ...
NYT News Service FDA weighs new COVID vaccine formula as policy limits boosters to high-risk groups. Fall 2025 vaccination plans remain uncertain with variant LP.8.1 in focus. CDC guidance expected ..
The FDA will limit COVID-19 vaccinations to those 65 and older or with health risks. Trump approves FEMA disaster relief for 8 states What it’s like to meet Tom Cruise in real life How much an ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65. New Poll Reveals Gavin Newsom’s Approval Rating U.S. Test-Fires ...